Nifedipine	Placebo	LDL cholesterol 	967	1151	Blood pressure was lower on nifedipine than on placebo by 5.8/2.1 mmHg (P < 0.001) as was total and LDL cholesterol (4.8 mg/dL; P = 0.495), while HDL was higher (3.6 mg/dL; P = 0.026).
Nifedipine	Placebo	Change in plaque volume	1277	1380	The percentage change in plaque volume with nifedipine and placebo, respectively, was 1.0 and 1.9%, ns.
Nifedipine	Placebo	Vasoconstriction to acetylcholine	1152	1276	In the most constricting segment, nifedipine reduced vasoconstriction to acetylcholine (14.0% vs. placebo 7.7%; P < 0.0088).
Nifedipine	Placebo	Blood pressure	967	1049	Blood pressure was lower on nifedipine than on placebo by 5.8/2.1 mmHg (P < 0.001)
Nifedipine	Placebo	Vasoconstriction to acetylcholine	1186	1276	nifedipine reduced vasoconstriction to acetylcholine (14.0% vs. placebo 7.7%; P < 0.0088).
Nifedipine	Placebo	HDL cholesterol 	967	1151	Blood pressure was lower on nifedipine than on placebo by 5.8/2.1 mmHg (P < 0.001) as was total and LDL cholesterol (4.8 mg/dL; P = 0.495), while HDL was higher (3.6 mg/dL; P = 0.026).
Nifedipine	Placebo	Blood pressure	967	1151	Blood pressure was lower on nifedipine than on placebo by 5.8/2.1 mmHg (P < 0.001) as was total and LDL cholesterol (4.8 mg/dL; P = 0.495), while HDL was higher (3.6 mg/dL; P = 0.026).
Nifedipine	Placebo	Change in plaque volume	19096	19220	Neither the difference in absolute nor relative changes between treatments was significant (P = 0.84 and 0.66, respectively;
